Equity Profile

CORZ

Core Scientific, Inc.

Information TechnologyApplication Software$8.2B

Mar28Tue

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Core Scientific, Inc. operates in the information technology sector, focusing on application software....

Key Metrics to Watch

Revenue Growth

This metric will indicate how well Core Scientific is expanding its business and capturing market share.

N/A

Earnings Per Share (EPS)

EPS is crucial for assessing the company's profitability and will influence investor sentiment.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

CORZ Q2-2026 Earnings Preview

Context

Company Snapshot

Core Scientific, Inc. operates in the information technology sector, focusing on application software. The company is significant as it plays a role in the growing demand for software solutions in various industries, particularly as businesses increasingly rely on technology to enhance efficiency and productivity.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

-2100.11%

Avg Stock Reaction

+3.57%

Last Quarter Recap

In the last quarter, Core Scientific reported an EPS of -$1.06, significantly missing estimates. Despite this, the stock rose by 11% the following day, indicating some investor optimism.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic about Core Scientific's upcoming earnings report, especially after the mixed results from the previous quarter. The market is looking for signs of recovery or growth in key metrics.

Bull Case

If Core Scientific can demonstrate strong revenue growth and improved customer acquisition, it could lead to a positive reassessment of the stock and further price appreciation.

Bear Case

Conversely, if the company fails to show improvement in its financial metrics or provides weak guidance, it may lead to a decline in stock price as investor confidence wanes.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth rate for this quarter?

This will provide insight into the company’s performance and ability to attract new customers, which is crucial for investor confidence.

How is the company addressing its recent EPS misses?

Understanding management's strategy to improve profitability will be key for investors looking for signs of recovery.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Core Scientific's potential for a turnaround, given its recent strategic initiatives that could drive customer growth.

Supporting Evidence

The stock's previous performance suggests that even a small positive surprise can lead to significant gains.

The options market is pricing a larger move than historical averages, indicating heightened expectations.

Insider selling may not reflect overall company health but could be a strategic move unrelated to company performance.

Key Risk

If the revenue growth exceeds expectations, it could shift the narrative around the company's recovery.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter centers around whether Core Scientific can turn its recent performance around and show meaningful growth.

Bull Confirmed If

Demonstrating revenue growth of at least 10% quarter-over-quarter would confirm the bull case.

Bear Confirmed If

An EPS loss greater than $1.00 would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±5.47%

Historical Avg

±4.5%

Pricing rich

The options market is pricing in a potential move of about 5.5% in either direction following the earnings report, suggesting uncertainty among investors.

Options are pricing ±5.5% while CORZ has averaged ±4.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.9%

30d HV

62.2%

Calls (8.5M)P/C Ratio: 0.20Puts (1.3M)

Edge

Historical Setup Match

Cross-company pattern from 29 similar setups.

Prior-quarter miss + options pricing rich in Information Technology

n=29

Fade rate: 9 of 29 (31%)

This setup has occurred 29 times across Information Technology in the last 2 years. 20 of 29 (69%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 8.2%, with a raw directional average of +3.5% (modestly positive historical bias).

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$384,199.24

20,000 sh

1 insider

Net

$384,199.24

Net selling

Most Active Insiders· 3 open-market trades

See remarksDUCHENE TODD M
$384,199.24
Net selling

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Core Scientific beats expectations, history suggests the stock could rise by about 0.92% on the first day, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further clarity from management.

Miss

If the company misses expectations, history suggests a potential decline of about 6.21%, leading to increased skepticism about its growth prospects.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on customer acquisition strategies and their effectiveness.
2Management's outlook on revenue growth for the upcoming quarters.
3Details on cost management initiatives and their impact on profitability.
4Insights into market trends that could affect demand for Core Scientific's products.
5Any commentary on competitive positioning within the application software sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

BioNTech SE

Company Snapshot

Core Scientific, Inc. operates in the information technology sector, focusing on application software....

Key Metrics to Watch

Revenue Growth

This metric will indicate how well Core Scientific is expanding its business and capturing market share.

N/A

Earnings Per Share (EPS)

EPS is crucial for assessing the company's profitability and will influence investor sentiment.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

CORZ Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

-2100.11%

Avg Stock Reaction

+3.57%

Last Quarter Recap

In the last quarter, Core Scientific reported an EPS of -$1.06, significantly missing estimates. Despite this, the stock rose by 11% the following day, indicating some investor optimism.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Core Scientific can demonstrate strong revenue growth and improved customer acquisition, it could lead to a positive reassessment of the stock and further price appreciation.

Bear Case

Conversely, if the company fails to show improvement in its financial metrics or provides weak guidance, it may lead to a decline in stock price as investor confidence wanes.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth rate for this quarter?

This will provide insight into the company’s performance and ability to attract new customers, which is crucial for investor confidence.

How is the company addressing its recent EPS misses?

Understanding management's strategy to improve profitability will be key for investors looking for signs of recovery.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Core Scientific's potential for a turnaround, given its recent strategic initiatives that could drive customer growth.

Supporting Evidence

The stock's previous performance suggests that even a small positive surprise can lead to significant gains.

The options market is pricing a larger move than historical averages, indicating heightened expectations.

Insider selling may not reflect overall company health but could be a strategic move unrelated to company performance.

Key Risk

If the revenue growth exceeds expectations, it could shift the narrative around the company's recovery.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter centers around whether Core Scientific can turn its recent performance around and show meaningful growth.

Bull Confirmed If

Demonstrating revenue growth of at least 10% quarter-over-quarter would confirm the bull case.

Bear Confirmed If

An EPS loss greater than $1.00 would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±5.47%

Historical Avg

±4.5%

Pricing rich

The options market is pricing in a potential move of about 5.5% in either direction following the earnings report, suggesting uncertainty among investors.

Options are pricing ±5.5% while CORZ has averaged ±4.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.9%

30d HV

62.2%

Calls (8.5M)P/C Ratio: 0.20Puts (1.3M)

Edge

Historical Setup Match

Cross-company pattern from 29 similar setups.

Prior-quarter miss + options pricing rich in Information Technology

n=29

Fade rate: 9 of 29 (31%)

Edge

Insider Activity

Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.

Bought

$0.00

0 sh

0 insiders

Sold

$384,199.24

20,000 sh

1 insider

Net

$384,199.24

Net selling

Most Active Insiders· 3 open-market trades

See remarksDUCHENE TODD M
$384,199.24
Net selling

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Core Scientific beats expectations, history suggests the stock could rise by about 0.92% on the first day, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further clarity from management.

Miss

If the company misses expectations, history suggests a potential decline of about 6.21%, leading to increased skepticism about its growth prospects.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on customer acquisition strategies and their effectiveness.
2Management's outlook on revenue growth for the upcoming quarters.
3Details on cost management initiatives and their impact on profitability.
4Insights into market trends that could affect demand for Core Scientific's products.
5Any commentary on competitive positioning within the application software sector.